A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,228,376 shares of PFE stock, worth $64.6 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
2,228,376
Previous 2,312,056 3.62%
Holding current value
$64.6 Million
Previous $64.2 Million 2.82%
% of portfolio
0.31%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$25.26 - $29.6 $2.11 Million - $2.48 Million
-83,680 Reduced 3.62%
2,228,376 $62.3 Million
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $19.2 Million - $22.1 Million
742,583 Added 47.31%
2,312,056 $64.2 Million
Q4 2023

Jan 24, 2024

BUY
$26.13 - $33.94 $6.17 Million - $8.02 Million
236,292 Added 17.72%
1,569,473 $45.2 Million
Q3 2023

Oct 26, 2023

BUY
$32.09 - $37.51 $3.5 Million - $4.09 Million
109,087 Added 8.91%
1,333,181 $44.2 Million
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $7.81 Million - $9.04 Million
216,291 Added 21.46%
1,224,094 $44.9 Million
Q1 2023

May 04, 2023

BUY
$39.39 - $51.28 $2.74 Million - $3.57 Million
69,648 Added 7.42%
1,007,803 $41.1 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $101,870 - $132,980
-2,440 Reduced 0.26%
938,155 $48.1 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $1.46 Million - $1.79 Million
33,428 Added 3.68%
940,595 $41.2 Million
Q2 2022

Jul 26, 2022

BUY
$46.53 - $55.17 $10.7 Million - $12.7 Million
230,644 Added 34.09%
907,167 $47.6 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $11.7 Million - $14.5 Million
-255,094 Reduced 27.38%
676,523 $35 Million
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $4.23 Million - $6.26 Million
102,276 Added 12.33%
931,617 $55 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $2.03 Million - $2.61 Million
51,826 Added 6.67%
829,341 $35.7 Million
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $2.85 Million - $3.22 Million
79,236 Added 11.35%
777,515 $30.4 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $10 Million - $11.3 Million
298,672 Added 74.74%
698,279 $25.3 Million
Q4 2020

Feb 10, 2021

BUY
$33.47 - $42.56 $572,069 - $727,435
17,092 Added 4.47%
399,607 $14.7 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $1.16 Million - $1.36 Million
36,401 Added 10.52%
382,515 $14 Million
Q2 2020

Aug 11, 2020

SELL
$30.12 - $36.54 $199,002 - $241,419
-6,607 Reduced 1.87%
346,114 $11.3 Million
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $204,968 - $292,855
-7,583 Reduced 2.1%
352,721 $11.5 Million
Q4 2019

Feb 12, 2020

SELL
$32.92 - $37.36 $568,791 - $645,506
-17,278 Reduced 4.58%
360,304 $14.1 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $1.56 Million - $2.02 Million
48,012 Added 14.57%
377,582 $13.6 Million
Q2 2019

Aug 13, 2019

SELL
$36.98 - $41.52 $1.49 Million - $1.67 Million
-40,217 Reduced 10.88%
329,570 $14.3 Million
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $13.5 Million - $14.8 Million
-359,643 Reduced 49.3%
369,787 $15.7 Million
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $461,832 - $526,539
-12,005 Reduced 1.62%
729,430 $31.8 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $12.3 Million - $14.9 Million
356,846 Added 92.79%
741,435 $32.7 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $23 Million - $24.6 Million
-698,528 Reduced 64.49%
384,589 $14 Million
Q1 2018

May 10, 2018

BUY
$31.91 - $37.02 $3.43 Million - $3.98 Million
107,516 Added 11.02%
1,083,117 $38.4 Million
Q4 2017

Feb 12, 2018

SELL
$33.26 - $35.29 $1.18 Million - $1.25 Million
-35,344 Reduced 3.5%
975,601 $35.3 Million
Q3 2017

Nov 08, 2017

SELL
$31.0 - $34.15 $1.26 Million - $1.39 Million
-40,627 Reduced 3.86%
1,010,945 $36.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,051,572
1,051,572 $35.3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.